Skip to content

Canceled by the investigator. Retrospective cohort study of the effect of Lianhua Qingwen capsule/granule on novel coronavirus infected persons

Multi center retrospective cohort study on the effect of Lianhua Qingwen capsule/granule on novel coronavirus infected persons

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300070804
Enrollment
Unknown
Registered
2023-04-24
Start date
2023-04-24
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronavirus diseaseNovel Coronavirus Pneumonia (COVID-19)

Interventions

Lianhua Qingwen Formation group:N/A
Do not give Lianhua Qingwen group:N/A

Sponsors

Shanghai Yangpu District Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Asymptomatic infection of novel coronavirus and mild confirmed cases in line with the Diagnosis and Treatment Plan for novel coronavirus Pneumonia (Trial Version 9) found by pathogenic detection; 2. Age 18 or above, male or female;

Exclusion criteria

Exclusion criteria: 1. Nucleic acid test is positive, and the patient is diagnosed as ordinary type, severe type and critical type of novel coronavirus pneumonia; 2. Those whose nucleic acid has turned negative;

Design outcomes

Primary

MeasureTime frame
The total negative rate of nucleic acid testing within 7 days after check-in in the shelter;

Secondary

MeasureTime frame
adverse event;Median time of nucleic acid negative conversion;

Countries

China

Contacts

Public ContactZhang Shufu

Shanghai Yangpu District Traditional Chinese Medicine Hospital

drzeng810@163.com+86 13068768911

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026